BRCA1 Versus BRCA2 and PARP Inhibitor Sensitivity in Prostate Cancer: More Different Than Alike?

Mark C. Markowski, Emmanuel S. Antonarakis

Research output: Contribution to journalReview articlepeer-review

37 Scopus citations
Original languageEnglish (US)
Pages (from-to)3735-3739
Number of pages5
JournalJournal of Clinical Oncology
Issue number32
StatePublished - Nov 10 2020
Externally publishedYes

Bibliographical note

Funding Information:
Supported by National Institutes of Health Cancer Center Support Grant P30CA006973 (E.S.A.) and a Prostate Cancer Foundation Young Investigator Award (M.C.M). The authors thank Alexander Baras for assistance with analysis and interpretation of the cBioPortal database and Su Jin Lim and Hao Wang for assistance with pooled biostatistical analyses

Cite this